Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...

Pharmacokinetic Models: Comparison and Selection Criterion

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Supramolecular Nanotheranostics.

Theranostics·2019

Same author

Length Effect on the Stress Detection of Prestressed Steel Strands Based on Electromagnetic Oscillation Method.

Sensors (Basel, Switzerland)·2019

Same author

Electrocatalytic oxidation toward dopamine and acetaminophen based on AuNPs@TCnA/GN modified glassy carbon electrode.

Analytica chimica acta·2019

Same author

Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status.

The American journal of surgical pathology·2019

Same author

A data review of airway management in patients with oral cavity or oropharyngeal cancer: a single-institution experience.

BMC anesthesiology·2019

Same author

Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2019

Search research articles

Related Experiment Video

Updated: Jul 10, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Genetic model selection in two-phase analysis for case-control association studies.

Gang Zheng¹, Hon Keung Tony Ng

¹Office of Biostatistics Research, National Heart, Lung and Blood Institute, 6701 Rockledge Drive, Bethesda, MD 20892-7931, USA.

Biostatistics (Oxford, England)

|November 16, 2007

Summary

This summary is machine-generated.

This study introduces a robust two-phase analysis for genetic association studies. It improves efficiency and Type-I error control when disease genetic models are unknown.

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Related Experiment Videos

Last Updated: Jul 10, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Area of Science:

Genetics
Statistical genetics
Epidemiology

Background:

The Cochran-Armitage trend test (CATT) is effective for genetic association studies when the genetic model is known.
Complex diseases often involve unknown genetic models, necessitating robust statistical approaches.
Existing methods may lack efficiency or proper Type-I error control in these scenarios.

Purpose of the Study:

To propose a novel two-phase analysis method for case-control studies with unknown genetic models.
To enhance the robustness and efficiency of genetic association testing.
To control Type-I error rates in complex disease association studies.

Main Methods:

A two-phase analysis approach is introduced for case-control designs.
Phase one utilizes the difference in Hardy-Weinberg disequilibrium coefficients for model selection.
An optimal CATT is applied in phase two, with derived correlations to adjust for Type-I error control.

Main Results:

The proposed two-phase method demonstrates greater efficiency robustness compared to existing approaches.
Simulation studies validate the improved performance of the new method.
The approach effectively controls the Type-I error rate.

Conclusions:

The novel two-phase analysis offers a more robust and efficient method for genetic association testing in complex diseases.
This approach is particularly valuable when underlying genetic models are unknown.
The method provides a reliable tool for identifying disease-associated genetic markers.